SAN DIEGO, CA and TAICANG, China, May 07, 2024 Connect Biopharma Holdings Limited , a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic.
PDUFA Target Action Date of June 26, 2024 Eight posters including two oral presentations support potential of ensifentrine,an investigational, first-in-class, selective, dual inhibitor of PDE3 and.
Verona Pharma To Present Additional Analyses Of Positive Phase 3 ENHANCE Studies In COPD At ATS 2024 menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid in IPFAdditional presentations include preclinical and translational data.
Vicore Pharma Holding: Vicore Announces Presentations at the 2024 American Thoracic Society International Conference finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.